Immunotherapy is the "treatment of disease by persuading, enhancing, or suppressing an immune response “Immunotherapies designed to elicit or amplify an immune response are underground as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, predominantly in its promise to treat various forms of cancer

Immunomodulatory regimens often have fewer side effects than existing drugs, as well as less potential for creating resistance when treating microbial disease.

Cell-based immunotherapies are actual for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumour cells.

Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. various chemokines, synthetic cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

  • Track 1-1 Activation immunotherapy
  • Track 2-2 Suppression immunotherapy
  • Track 3-3 Monoclonal antibodies
  • Track 4-4 Immune checkpoint inhibitors
  • Track 5-5 Cancer vaccines
  • Track 6-6 Dendritic cell therapy

Related Conference of Immunology